Renub

    Breast Cancer Screening Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Apr 2023
    Pages: 450

    Breast Cancer Screening Market Outlook

    Global Breast Cancer Screening Market will reach US$ 2.13 Billion in 2028, according to Renub Research. Breast cancer screening can detect cancer early, even before any symptoms are present. Early detection is vital because it allows for more effective treatment options and increases the chances of a successful outcome. When breast cancer is detected early, more treatment options are available, including less invasive treatments and the possibility of breast-conserving surgery. In addition, breast cancer screening is cost-effective, as the cost of screening is significantly lower than that of treating advanced breast cancer.

    breast-cancer-screening-market


    Breastcancer.org's 2022 update projects that in the United States, 287,850 individuals received a diagnosis of invasive breast cancer, and an additional 51,400 individuals were diagnosed with non-invasive (in situ) breast cancer


    Breast cancer screening markets shall experience a CAGR of 4.45% from 2022 to 2028

    The demand for breast cancer screening services has been increasing due to the rising incidence of breast cancer worldwide. According to the World Health Organization (WHO), breast cancer is the most prevalent type of cancer globally, with over 2.3 million new cases. A growing awareness has fuelled this rise in demand for screening services among women about the importance of breast cancer screening. As a result, women are encouraged to undergo screening through various campaigns, educational programs, and advocacy groups. Additionally, the aging of the population has also played a role in the increased demand for breast cancer screening services, as frequent diagnosis of breast cancer is common in older women.

    Governments have implemented screening programs and policies to increase access to breast cancer screening, particularly for underserved populations. In addition, technological advancements have led to the development of more accurate and less invasive screening methods, such as digital mammography, breast ultrasound, and magnetic resonance imaging (MRI), which have improved the detection of breast cancer. For instance, in March 2022, LifeCell launched Breast Screen Panel, a comprehensive genetic screening test assessing women's risk of breast cancer. Hence, the market value for the global breast cancer screening market was US$ 1.64 Billion in 2022.


    Increased Awareness, Technological Advancements, and Government Initiatives have led to the growing demand for Breast Cancer Screening Services in India

    Countries present in the breast cancer screening market are the United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, United Arab Emirates, Saudi Arabia, and Rest of World. Increasing disposable income in India has allowed more individuals to afford breast cancer screening services, awareness campaigns, and government initiatives, raising women's awareness about the importance of breast cancer screening and improving access to screening services, particularly for underserved populations. In addition, government initiatives such as the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) and the National Health Mission (NHM) have improved access to breast cancer screening in India.

    In China, improved access to healthcare services, including breast cancer screening, can be attributed to the country's recent increase in healthcare spending. Additionally, the Chinese government has launched various initiatives to improve access to breast cancer screening, focusing on underserved populations. An example of such an initiative is the National Breast Cancer Screening Program, which offers free breast cancer screening to women living in rural areas.


    High Incidence of Breast Cancer in the United States has increased the emphasis on Breast Cancer Screening

    Based on the Mammography breast cancer screening, there are 24 divisions - United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, United Arab Emirates, Saudi Arabia, and Rest of World. Health insurance plans cover mammography, making it more accessible and affordable. In addition, advanced mammography technology has improved the accuracy of screening. The government has implemented policies to increase access to mammography, including initiatives to achieve "zero fatalities from breast cancer" by 2030, as announced by the National Breast Cancer Foundation, with USD 12.4 Million in funding for 20 research initiatives.


    Private Healthcare Sector in Brazil Embraces Advanced Breast Cancer Screening Technologies Amid Growing Awareness among Women.

    The countries where MRI breast cancer screening is prevalent are the United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and Rest of World. The private healthcare sector in Brazil has been investing in advanced breast cancer screening technologies, including MRI, to provide more accurate and effective screening services. Furthermore, there has been a growing awareness among women in Brazil about the importance of breast cancer screening, driven by campaigns, educational programs, and advocacy groups.


    China shall have the Highest Share in the Ultrasound Screening Industry

    United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and Rest of World, is the different countries in the ultrasound breast cancer screening market. Ultrasound screening is safe and effective, particularly for younger women and women with dense breast tissue. The Chinese government has implemented initiatives to increase access to breast cancer screening, including promoting ultrasound screening as a primary screening method.

    Additionally, the development and adoption of advanced ultrasound technology have improved the accuracy and effectiveness of ultrasound screening in detecting breast cancer.

    There has been a growing emphasis on using ultrasound screening as a complement to mammography, particularly for women with dense breast tissue leading to increased adoption and utilization of ultrasound screening in the United States. Moreover, the United States has been a leader in developing and adopting advanced ultrasound technology, including 3D and 4D ultrasound, improving the accuracy and effectiveness of ultrasound screening in detecting breast cancer.


    Key Players Analysis

    AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc are significant companies competing in Breast Cancer Screening Market.

    • In June 2022, Walmart signed a general merchandise supplier agreement with Biomerica, Inc to sell the Aware Breast Self-Exam device in its retail system.


    Renub Research report titled “Global Breast Cancer Screening Market Global Forecast by breast cancer screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), Mammography screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), MRI Screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW) Ultrasound Screening (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway, Netherlands, New Zealand, Australia, United States, Canada, Japan, Korea, Singapore, India, Thailand, Malaysia, China, Brazil, South Africa, UAE, Saudi Arabia, and ROW), Company Analysis (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc)" provides a detailed analysis of Global breast cancer screening Market.

    breast-cancer-screening-market-share

    Breast Cancer Screening- Market breakup of 24 Countries:

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Switzerland
    7.    Norway
    8.    Netherlands
    9.    New Zealand
    10.    Australia
    11.    United States
    12.    Canada
    13.    Japan
    14.    Korea
    15.    Singapore
    16.    India
    17.    Thailand
    18.    Malaysia
    19.    China
    20.    Brazil
    21.    South Africa
    22.    United Arab Emirates
    23.    Saudi Arabia
    24.     Rest of World


    Mammography Screening - Market breakup from 24 Viewpoints:

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Switzerland
    7.    Norway
    8.    Netherlands
    9.    New Zealand
    10.    Australia
    11.    United States
    12.    Canada
    13.    Japan
    14.    Korea
    15.    Singapore
    16.    India
    17.    Thailand
    18.    Malaysia
    19.    China
    20.    Brazil
    21.    South Africa
    22.    United Arab Emirates
    23.    Saudi Arabia
    24.    Rest of World


    MRI Screening- Market breakup from 24 Viewpoints:

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Switzerland
    7.    Norway
    8.    Netherlands
    9.    New Zealand
    10.    Australia
    11.    United States
    12.    Canada
    13.    Japan
    14.    Korea
    15.    Singapore
    16.    India
    17.    Thailand
    18.    Malaysia
    19.    China
    20.    Brazil
    21.    South Africa
    22.    United Arab Emirates
    23.    Saudi Arabia
    24.    Rest of World


    Ultrasound Screening- Market breakup from 24 Viewpoints:

    1.    United Kingdom
    2.    France
    3.    Germany
    4.    Italy
    5.    Spain
    6.    Switzerland
    7.    Norway
    8.    Netherlands
    9.    New Zealand
    10.    Australia
    11.    United States
    12.    Canada
    13.    Japan
    14.    Korea
    15.    Singapore
    16.    India
    17.    Thailand
    18.    Malaysia
    19.    China
    20.    Brazil
    21.    South Africa
    22.    United Arab Emirates
    23.    Saudi Arabia
    24.    Rest of World


    Company has been covered from 3 Viewpoints:

    •    Overview 
    •    Recent Development
    •    Revenue


    Company Analysis:

    1.    AstraZeneca
    2.    Novartis
    3.    Sanofi
    4.    Pfizer
    5.    Bayer AG
    6.    GlaxoSmithKline plc

    1.    Introduction

    2.    Research Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Porter’s Five Forces

    5.1    Bargaining Power of Buyers
    5.2    Bargaining Power of Suppliers
    5.3    Degree of Competition
    5.4    Threat of New Entrants
    5.5    Threat of Substitutes


    6.    Global Breast Cancer Screening Market

    6.1    Market 
    6.2    Population (Thousand)


    7.    By Types - Global Breast Cancer Screening Population

    7.1    Mammography Screening Population
    7.2    MRI & Ultrasound Screening Population


    8.    By Types - Global Breast Cancer Screening Market

    8.1    Mammography Screening Market
    8.2    Magnetic Resonance Imaging (MRI) Screening Market
    8.3    Ultrasound Screening Market


    9.    Population Share – Global Breast Cancer Screening

    9.1    Breast Cancer Screening
    9.2    Mammography Screening
    9.3    MRI & Ultrasound Screening


    10.    Market Share – Global Breast Cancer Screening

    10.1     Breast Cancer Screening
    10.2     Mammography Screening
    10.3     MRI Screening
    10.4     Ultrasound Screening


    11.    United Kingdom – Breast Cancer Screening Population & Market

    11.1    United Kingdom Breast Cancer Screening Population & Forecast

    11.1.1    Mammography Screening Population
    11.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    11.2    United Kingdom Breast Cancer Screening Market & Forecast

    11.2.1    Mammography Screening Market
    11.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    11.2.3    Ultrasound Screening Market


    12.    France – Breast Cancer Screening Population & Market

    12.1    France Breast Cancer Screening Population & Forecast

    12.1.1    Mammography Screening Population
    12.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    12.2    France Breast Cancer Screening Market & Forecast

    12.2.1    Breast Cancer Mammography Screening Market
    12.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    12.2.3    Ultrasound Screening Market


    13.    Germany – Breast Cancer Screening Population & Market

    13.1    Germany Breast Cancer Screening Population & Forecast

    13.1.1    Mammography Screening Population
    13.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    13.2    Germany Breast Cancer Screening Market & Forecast

    13.2.1    Breast Cancer Mammography Screening Market
    13.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    13.2.3    Ultrasound Screening Market


    14.    Italy – Breast Cancer Screening Population & Market

    14.1    Italy Breast Cancer Screening Population & Forecast

    14.1.1    Mammography Screening Population
    14.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    14.2    Italy Breast Cancer Screening Market & Forecast

    14.2.1    Mammography Screening Market
    14.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    14.2.3    Ultrasound Screening Market


    15.    Spain – Breast Cancer Screening Population & Market

    15.1    Spain Breast Cancer Screening Population & Forecast

    15.1.1    Mammography Screening Population
    15.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    15.2    Spain Breast Cancer Screening Market & Forecast

    15.2.1    Mammography Screening Market
    15.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    15.2.3    Ultrasound Screening Market


    16.    Switzerland – Breast Cancer Screening Population & Market

    16.1    Switzerland Breast Cancer Screening Population & Forecast

    16.1.1    Mammography Screening Population
    16.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    16.2    Switzerland Breast Cancer Screening Market & Forecast

    16.2.1    Mammography Screening Market
    16.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    16.2.3    Ultrasound Screening Market


    17.    Norway – Breast Cancer Screening Population & Market

    17.1    Norway Breast Cancer Screening Population & Forecast

    17.1.1    Mammography Screening Population
    17.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    17.2    Norway Breast Cancer Screening Market & Forecast

    17.2.1    Mammography Screening Market
    17.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    17.2.3    Ultrasound Screening Market


    18.    Netherlands – Breast Cancer Screening Population & Market

    18.1    Netherlands Breast Cancer Screening Population & Forecast

    18.1.1    Mammography Screening Population
    18.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    18.2    Netherlands Breast Cancer Screening Market & Forecast

    18.2.1    Mammography Screening Market
    18.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    18.2.3    Ultrasound Screening Market


    19.    United States – Breast Cancer Screening Population & Market

    19.1    United States Breast Cancer Screening Population & Forecast

    19.1.1    Mammography Screening Population
    19.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    19.2    United States Breast Cancer Screening Market & Forecast

    19.2.1    Mammography Screening Market
    19.2.2    Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market
    19.2.3    Ultrasound Screening Market


    20.    Canada – Breast Cancer Screening Population & Market

    20.1    Canada Breast Cancer Screening Population & Forecast

    20.1.1    Mammography Screening Population
    20.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    20.2    Canada Breast Cancer Screening Market & Forecast

    20.2.1    Mammography Screening Market
    20.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    20.2.3    Ultrasound Screening Market


    21.    Japan – Breast Cancer Screening Population & Market

    21.1    Japan Breast Cancer Screening Population & Forecast

    21.1.1    Mammography Screening Population
    21.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    21.2    Japan Breast Cancer Screening Market & Forecast

    21.2.1    Mammography Screening Market
    21.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    21.2.3    Ultrasound Screening Market


    22.    Korea – Breast Cancer Screening Population & Market

    22.1    Korea Breast Cancer Screening Population & Forecast

    22.1.1    Mammography Screening Population
    22.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    22.2    Korea Breast Cancer Screening Market & Forecast

    22.2.1    Mammography Screening Market
    22.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    22.2.3    Ultrasound Screening Market


    23.    Singapore – Breast Cancer Screening Population & Market

    23.1    Singapore Breast Cancer Screening Population & Forecast

    23.1.1    Mammography Screening Population
    23.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    23.2    Singapore Breast Cancer Screening Market & Forecast

    23.2.1    Mammography Screening Market
    23.2.2    Resonance Imaging (MRI) Screening Market
    23.2.3    Ultrasound Screening Market


    24.    Malaysia – Breast Cancer Screening Population & Market

    24.1    Malaysia Breast Cancer Screening Population & Forecast

    24.1.1    Mammography Screening Population
    24.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    24.2    Malaysia Breast Cancer Screening Market & Forecast

    24.2.1    Mammography Screening Market
    24.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    24.2.3    Ultrasound Screening Market


    25.    India – Breast Cancer Screening Population & Market

    25.1    India Breast Cancer Screening Population & Forecast

    25.1.1    Mammography Screening Population
    25.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    25.2    India Breast Cancer Screening Market & Forecast

    25.2.1    Mammography Screening Market
    25.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    25.2.3    Ultrasound Screening Market


    26.    China – Breast Cancer Screening Population & Market

    26.1    China Breast Cancer Screening Population & Forecast

    26.1.1    Mammography Screening Population
    26.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    26.2    China Breast Cancer Screening Market & Forecast

    26.2.1    Mammography Screening Market
    26.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    26.2.3    Ultrasound Screening Market


    27.    Thailand – Breast Cancer Screening Population & Market

    27.1    Thailand Breast Cancer Screening Population & Forecast

    27.1.1    Mammography Screening Population
    27.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    27.2    Thailand Breast Cancer Screening Market & Forecast

    27.2.1    Mammography Screening Market
    27.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    27.2.3    Ultrasound Screening Market


    28.    Brazil – Breast Cancer Screening Population & Market

    28.1    Brazil Breast Cancer Screening Population & Forecast

    28.1.1    Mammography Screening Population
    28.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    28.2    Brazil Breast Cancer Screening Market & Forecast

    28.2.1    Mammography Screening Market
    28.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    28.2.3    Ultrasound Screening Market


    29.    Australia – Breast Cancer Screening Population & Market

    29.1    Australia Breast Cancer Screening Population & Forecast

    29.1.1    Mammography Screening Population
    29.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    29.2    Australia Breast Cancer Screening Market & Forecast

    29.2.1    Mammography Screening Market
    29.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    29.2.3    Ultrasound Screening Market


    30.    New Zealand – Breast Cancer Screening Population & Market

    30.1    New Zealand Breast Cancer Screening Population & Forecast

    30.1.1    Mammography Screening Population
    30.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    30.2    New Zealand Breast Cancer Screening Market & Forecast

    30.2.1    Mammography Screening Market
    30.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    30.2.3    Ultrasound Screening Market


    31.    South Africa – Breast Cancer Screening Population & Market

    31.1    South Africa Breast Cancer Screening Population & Forecast

    31.1.1    Mammography Screening Population
    31.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    31.2    South Africa Breast Cancer Screening Market & Forecast

    31.2.1    Mammography Screening Market
    31.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    31.2.3    Ultrasound Screening Market


    32.    United Arab Emirates – Breast Cancer Screening Population & Market

    32.1    United Arab Emirates Breast Cancer Screening Population & Forecast

    32.1.1    Mammography Screening Population
    32.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    32.2    United Arab Emirates Breast Cancer Screening Market & Forecast

    32.2.1    Mammography Screening Market
    32.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    32.2.3    Ultrasound Screening Market


    33.    Saudi Arabia – Breast Cancer Screening Population & Market

    33.1    Saudi Arabia Breast Cancer Screening Population & Forecast

    33.1.1    Mammography Screening Population
    33.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    33.2    Saudi Arabia Breast Cancer Screening Market & Forecast

    33.2.1    Mammography Screening Market
    33.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    33.2.3    Ultrasound Screening Market


    34.    ROW – Breast Cancer Screening Population & Market

    34.1    ROW Breast Cancer Screening Population & Forecast

    34.1.1    Mammography Screening Population
    34.1.2    Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population

    34.2    ROW Breast Cancer Screening Market & Forecast

    34.2.1    Mammography Screening Market
    34.2.2    Magnetic Resonance Imaging (MRI) Screening Market
    34.2.3    Ultrasound Screening Market


    35.    Company Analysis 

    35.1    AstraZeneca

    35.1.1    Overviews
    35.1.2    Resent Development
    35.1.3    Revenue 

    35.2    Novartis

    35.2.1    Overviews
    35.2.2    Resent Development
    35.2.3    Revenue 

    35.3    Sanofi

    35.3.1    Overviews
    35.3.2    Resent Development
    35.3.3    Revenue 

    35.4    Pfizer

    35.4.1    Overviews
    35.4.2    Resent Development
    35.4.3    Revenue 

    35.5    Bayer AG

    35.5.1    Overviews
    35.5.2    Resent Development
    35.5.3    Revenue 

    35.6    GlaxoSmithKline plc

    35.6.1    Overviews
    35.6.2    Resent Development
    35.6.3    Revenue 


    List of Figures:

    Figure-01:    Global – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-02:    Global – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-03:    Global – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-04:    Global – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-05:    Global – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-06:    Global – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-07:    Global – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-08:    Global – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-09:    Global – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-10:    Global – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-11:    United Kingdom – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-12:    United Kingdom – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-13:    United Kingdom – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-14:    United Kingdom – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-15:    United Kingdom – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-16:    United Kingdom – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-17:    United Kingdom – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-18:    United Kingdom – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-19:    United Kingdom – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-20:    United Kingdom – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-21:    France – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-22:    France – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-23:    France – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-24:    France – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-25:    France – Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-26:    France – Forecast for Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-27:    France – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-28:    France – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-29:    France – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-30:    France – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-31:    Germany – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-32:    Germany – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-33:    Germany – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-34:    Germany – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-35:    Germany – Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-36:    Germany – Forecast for Breast Cancer Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-37:    Germany – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-38:    Germany – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-39:    Germany – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-40:    Germany – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-41:    Italy – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-42:    Italy – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-43:    Italy – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-44:    Italy – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-45:    Italy – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-46:    Italy – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-47:    Italy – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-48:    Italy – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-49:    Italy – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-50:    Italy – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-51:    Spain – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-52:    Spain – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-53:    Spain – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-54:    Spain – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-55:    Spain – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-56:    Spain – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-57:    Spain – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-58:    Spain – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-59:    Spain – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-60:    Spain – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-61:    Switzerland – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-62:    Switzerland – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-63:    Switzerland – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-64:    Switzerland – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-65:    Switzerland – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-66:    Switzerland – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-67:    Switzerland – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-68:    Switzerland – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-69:    Switzerland – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-70:    Switzerland – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-71:    Norway – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-72:    Norway – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-73:    Norway – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-74:    Norway – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-75:    Norway – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-76:    Norway – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-77:    Norway – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-78:    Norway – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-79:    Norway – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-80:    Norway – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-81:    Netherlands – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-82:    Netherlands – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-83:    Netherlands – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-84:    Netherlands – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-85:    Netherlands – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-86:    Netherlands – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-87:    Netherlands – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-88:    Netherlands – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-89:    Netherlands – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-90:    Netherlands – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-91:    United States – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-92:    United States – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-93:    United States – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-94:    United States – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-95:    United States – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-96:    United States – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-97:    United States – Breast Cancer Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-98:    United States – Forecast for Breast Cancer Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-99:    United States – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-100:    United States – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-101:    Canada – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-102:    Canada – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-103:    Canada – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-104:    Canada – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-105:    Canada – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-106:    Canada – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-107:    Canada – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-108:    Canada – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-109:    Canada – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-110:    Canada – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-111:    Japan – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-112:    Japan – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-113:    Japan – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-114:    Japan – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-115:    Japan – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-116:    Japan – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-117:    Japan – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-118:    Japan – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-119:    Japan – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-120:    Japan – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-121:    Korea – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-122:    Korea – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-123:    Korea – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-124:    Korea – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-125:    Korea – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-126:    Korea – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-127:    Korea – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-128:    Korea – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-129:    Korea – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-130:    Korea – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-131:    Singapore – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-132:    Singapore – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-133:    Singapore – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-134:    Singapore – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-135:    Singapore – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-136:    Singapore – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-137:    Singapore – Breast Cancer Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-138:    Singapore – Forecast for Breast Cancer Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-139:    Singapore – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-140:    Singapore – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-141:    Malaysia – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-142:    Malaysia – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-143:    Malaysia – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-144:    Malaysia – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-145:    Malaysia – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-146:    Malaysia – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-147:    Malaysia – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-148:    Malaysia – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-149:    Malaysia – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-150:    Malaysia – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-151:    India – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-152:    India – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-153:    India – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-154:    India – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-155:    India – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-156:    India – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-157:    India – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-158:    India – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-159:    India – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-160:    India – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-161:    China – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-162:    China – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-163:    China – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-164:    China – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-165:    China – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-166:    China – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-167:    China – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-168:    China – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-169:    China – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-170:    China – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-171:    Thailand – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-172:    Thailand – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-173:    Thailand – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-174:    Thailand – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-175:    Thailand – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-176:    Thailand – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-177:    Thailand – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-178:    Thailand – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-179:    Thailand – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-180:    Thailand – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-181:    Brazil – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-182:    Brazil – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-183:    Brazil – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-184:    Brazil – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-185:    Brazil – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-186:    Brazil – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-187:    Brazil – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-188:    Brazil – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-189:    Brazil – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-190:    Brazil – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-191:    Australia – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-192:    Australia – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-193:    Australia – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-194:    Australia – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-195:    Australia – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-196:    Australia – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-197:    Australia – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-198:    Australia – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-199:    Australia – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-200:    Australia – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-201:    New Zealand – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-202:    New Zealand – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-203:    New Zealand – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-204:    New Zealand – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-205:    New Zealand – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-206:    New Zealand – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-207:    New Zealand – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-208:    New Zealand – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-209:    New Zealand – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-210:    New Zealand – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-211:    South Africa – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-212:    South Africa – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-213:    South Africa – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-214:    South Africa – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-215:    South Africa – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-216:    South Africa – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-217:    South Africa – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-218:    South Africa – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-219:    South Africa – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-220:    South Africa – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-221:    United Arab Emirates – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-222:    United Arab Emirates – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-223:    United Arab Emirates – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-224:    United Arab Emirates – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-225:    United Arab Emirates – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-226:    United Arab Emirates – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-227:    United Arab Emirates – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Thousand US$), 2018 – 2022
    Figure-228:    United Arab Emirates – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Thousand US$), 2023 – 2028
    Figure-229:    United Arab Emirates – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-230:    United Arab Emirates – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-231:    Saudi Arabia – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-232:    Saudi Arabia – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-233:    Saudi Arabia – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-234:    Saudi Arabia – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-235:    Saudi Arabia – Breast Cancer Mammography Screening Market (Thousand US$), 2018 – 2022
    Figure-236:    Saudi Arabia – Forecast for Breast Cancer Mammography Screening Market (Thousand US$), 2023 – 2028
    Figure-237:    Saudi Arabia – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-238:    Saudi Arabia – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-239:    Saudi Arabia – Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 – 2022
    Figure-240:    Saudi Arabia – Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2023 – 2028
    Figure-241:    Rest of World – Breast Cancer Mammography Screening Population Volume (Thousand), 2018 – 2022
    Figure-242:    Rest of World – Forecast for Breast Cancer Mammography Screening Population Volume (Thousand), 2023 – 2028
    Figure-243:    Rest of World – Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2018 – 2022
    Figure-244:    Rest of World – Forecast for Breast Cancer MRI and Ultrasound Screening Population Volume (Thousand), 2023 – 2028
    Figure-245:    Rest of World – Breast Cancer Mammography Screening Market (Million US$), 2018 – 2022
    Figure-246:    Rest of World – Forecast for Breast Cancer Mammography Screening Market (Million US$), 2023 – 2028
    Figure-247:    Rest of World – Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2018 – 2022
    Figure-248:    Rest of World – Forecast for Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market (Million US$), 2023 – 2028
    Figure-249:    Rest of World – Breast Cancer Ultrasound Screening Market (Million US$), 2018 – 2022
    Figure-250:    Rest of World – Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2023 – 2028
    Figure-251:    AstraZeneca – Global Revenue (Billion US$), 2018 – 2022
    Figure-252:    AstraZeneca – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-253:    Novartis – Global Revenue (Billion US$), 2018 – 2022
    Figure-254:    Novartis – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-255:    Sanofi – Global Revenue (Billion US$), 2018 – 2022
    Figure-256:    Sanofi – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-257:    Pfizer – Global Revenue (Billion US$), 2018 – 2022
    Figure-258:    Pfizer – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-259:    Bayer AG – Global Revenue (Billion US$), 2018 – 2022
    Figure-260:    Bayer AG – Forecast for Global Revenue (Billion US$), 2023 – 2028
    Figure-261:    GlaxoSmithKline plc – Global Revenue (Billion US$), 2018 – 2022
    Figure-262:    GlaxoSmithKline plc – Forecast for Global Revenue (Billion US$), 2023 – 2028


    List of Tables:

    Table-01:    Global – Breast Cancer Screening Population Share by Countries (Percent), 2018 – 2022
    Table-02:    Global – Forecast for Breast Cancer Screening Population Share by Countries (Percent), 2023 – 2028
    Table-03:    Global – Mammography Screening Population Share by Countries (Percent), 2018 – 2022
    Table-04:    Global – Forecast for Mammography Screening Population Share by Countries (Percent), 2023 – 2028
    Table-05:    Global – MRI and Ultrasound Screening Population Share by Countries (Percent), 2018 – 2022
    Table-06:    Global – Forecast for MRI and Ultrasound Screening Population Share by Countries (Percent), 2023 – 2028
    Table-07:    Global – Breast Cancer Screening Market Share by Countries (Percent), 2018 – 2022
    Table-08:    Global – Forecast for Breast Cancer Screening Market Share by Countries (Percent), 2023 – 2028
    Table-09:    Global – Mammography Screening Market Share by Countries (Percent), 2018 – 2022
    Table-10:    Global – Forecast for Mammography Screening Market Share by Countries (Percent), 2023 – 2028
    Table-11:    Global – MRI Screening Market Share by Countries (Percent), 2018 – 2022
    Table-12:    Global – Forecast for MRI Screening Market Share by Countries (Percent), 2023 – 2028
    Table-13:    Global – Ultrasound Screening Market Share by Countries (Percent), 2018 – 2022
    Table-14:    Global – Forecast for Ultrasound Screening Market Share by Countries (Percent), 2023 – 2028

    • Description
      Price
    • Chapter 1 & 4     Pages : 4
      $200
    • Chapter 5     Pages : 5
      $200
    • Chapter 6     Pages : 4
      $300
    • Chapter 7     Pages : 4
      $300
    • Chapter 8     Pages : 6
      $400
    • Chapter 11     Pages : 10
      $400
    • Chapter 12     Pages : 10
      $400
    • Chapter 13     Pages : 10
      $400
    • Chapter 14     Pages : 10
      $400
    • Chapter 15     Pages : 10
      $400
    • Chapter 16     Pages : 10
      $400
    • Chapter 17     Pages : 10
      $400
    • Chapter 18     Pages : 10
      $400
    • Chapter 19     Pages : 10
      $400
    • Chapter 20     Pages : 10
      $400
    • Chapter 21     Pages : 10
      $400
    • Chapter 22     Pages : 10
      $400
    • Chapter 23     Pages : 10
      $400
    • Chapter 24     Pages : 10
      $400
    • Chapter 25     Pages : 10
      $400
    • Chapter 26     Pages : 10
      $400
    • Chapter 27     Pages : 10
      $400
    • Chapter 28     Pages : 10
      $400
    • Chapter 29     Pages : 10
      $400
    • Chapter 30     Pages : 10
      $400
    • Chapter 31     Pages : 10
      $400
    • Chapter 32     Pages : 10
      $400
    • Chapter 33     Pages : 10
      $400
    • Chapter 34     Pages : 10
      $400
    • Chapter 35.1     Pages : 5
      $150
    • Chapter 35.2     Pages : 5
      $150
    • Chapter 35.3     Pages : 5
      $150
    • Chapter 35.4     Pages : 5
      $150
    • Chapter 35.5     Pages : 5
      $150
    • Chapter 35.6     Pages : 5
      $150

    Related Reports